Show
Sort by
-
Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice
-
Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments
-
A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment
-
High efficiency cell-specific targeting of cytokine activity
-
High efficiency targeting of interferon α activity